These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 25453804

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Computational Refinement and Validation Protocol for Proteins with Large Variable Regions Applied to Model HIV Env Spike in CD4 and 17b Bound State.
    Rasheed M, Bettadapura R, Bajaj C.
    Structure; 2015 Jun 02; 23(6):1138-49. PubMed ID: 26039348
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Functional design of potential inhibitors of human immunodeficiency virus (HIV) binding to CD4+ target cells: a molecular model of gp120 predicts ligand binding.
    Gabriel JL, Mitchell WM.
    Drug Des Discov; 1996 Oct 02; 14(2):103-14. PubMed ID: 9010617
    [Abstract] [Full Text] [Related]

  • 48. Identification of putative, stable binding regions through flexibility analysis of HIV-1 gp120.
    Tan H, Rader AJ.
    Proteins; 2009 Mar 02; 74(4):881-94. PubMed ID: 18704932
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Short peptides with induced beta-turn inhibit the interaction between HIV-1 gp120 and CD4.
    Choi YH, Rho WS, Kim ND, Park SJ, Shin DH, Kim JW, Im SH, Won HS, Lee CW, Chae CB, Sung YC.
    J Med Chem; 2001 Apr 26; 44(9):1356-63. PubMed ID: 11311058
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Comparative analysis of the gp120-binding area of murine and human CD4 molecules.
    Siddiqi MA, Tachibana M, Ohta S, Ikegami Y, Tahara-Hanaoka S, Huang YY, Shinohara N.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan 01; 14(1):7-12. PubMed ID: 8989204
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Blocking HIV-1 gp120 at the Phe43 cavity: if the extension fits….
    Dey B, Berger EA.
    Structure; 2013 Jun 04; 21(6):871-2. PubMed ID: 23747109
    [Abstract] [Full Text] [Related]

  • 59. Synthesis of dipeptide-type human immunodeficiency virus (HIV) protease inhibitors with a binding unit to gp120.
    Asagarasu A, Takayanagi N, Achiwa K.
    Chem Pharm Bull (Tokyo); 1998 May 04; 46(5):867-70. PubMed ID: 9621421
    [Abstract] [Full Text] [Related]

  • 60. A new class of viral inhibitor.
    Nat Biotechnol; 1997 Feb 04; 15(2):135. PubMed ID: 9035136
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.